Quo Vadis Vaccine Research Trends of Coronavirus Disease-19 in Indonesia and Malaysia: A Bibliometric Analysis
DOI:
https://doi.org/10.46507/jcgpp.v4i2.183Keywords:
Bibliometric Analysis, COVID-19 Vaccine, Research TrendsAbstract
The Coronavirus Disease-19 (COVID-19) has become a centre of attention for several countries, including Indonesia and Malaysia. The two countries are trying to maintain the stability and security of each country from the impact that will be caused. The Indonesian and Malaysian governments decided to import vaccines from several countries to reduce the spread of the disease in the global community. However, to deal with the limitations of imported vaccines, Malaysia and Indonesia are conducting various studies related to COVID-19 vaccine research. This study will observe how Indonesia and Malaysia respond to vaccine research trends related to COVID-19 from 2020 to 2022. This study uses a qualitative descriptive method that is produced through bibliometric analysis to analyse data collected from Scopus. In addition, the authors also use several kinds of literature from reputable journals to add references and information related to the research. The results of the bibliometric analysis show that Malaysia has paid more attention to research publications related to COVID-19 than Indonesia. However, Indonesia has received official approval for its first vaccine since September 2021, while Malaysia is in the process of developing its own vaccine. The authors assume this is because Malaysia manages its own local vaccines, while Indonesia does the opposite.
References
AlKhaldi, M., James, N., Chattu, V. K., Ahmed, S., Meghari, H., Kaiser, K., IJsselmuiden, C., & Tanner, M. (2021). Rethinking and strengthening the Global Health Diplomacy through triangulated nexus between policy makers, scientists and the community in light of COVID-19 global crisis. Global Health Research and Policy, 6(12), 1–6. https://doi.org/10.1186/s41256-021-00195-2
Alwi, S. A. R. S., Rafidah, E., Zurraini, A., Juslina, O., Brohi, I. B., & Lukas, S. (2021). A survey on COVID-19 vaccine acceptance and concern among Malaysians. BMC Public Health, 21(1129), 1–12. https://doi.org/10.1186/s12889-021-11071-6
Antonakis, J. (2021). Leadership to defeat COVID-19. Group Processes and Intergroup Relations, 24(2), 210–215. https://doi.org/10.1177/1368430220981418
Arifin, B., & Anas, T. (2021). Lessons learned from COVID-19 vaccination in Indonesia: experiences, challenges, and opportunities. Human Vaccines & Immunotherapeutics, 17(11), 3898-3906.
Azoulay, P., & Jones, B. (2020). Beat COVID-19 through innovation. Science, 368(6491), 553. https://doi.org/10.1126/science.abc5792
Baas, J., Schotten, M., Plume, A., Côté, G., & Karimi, R. (2020). Scopus as a curated, high-quality bibliometric data source for academic research in quantitative science studies. Quantitative Science Studies, 1(1), 377–386.
Badr, H. S., Du, H., Marshall, M., Dong, E., Squire, M. M., & Gardner, L. M. (2020). Association between mobility patterns and COVID-19 transmission in the USA: Amathematical modelling study. The Lancet Infectious Diseases, 20(11), 1247–1254.
Balmford, B., Annan, J. D., Hargreaves, J. C., Altoè, M., & Bateman, I. J. (2020). Cross‑country comparisons of COVID‑19: Policy, politics and the price of life. Environmental and Resource Economics, 76(4), 525–551. https://doi.org/10.1007/s10640-020-00466-5
Bauchner, H., Malani, P. N., & Sharfstein, J. (2020). Reassuring the public and clinical community about the scientific review and approval of a COVID-19 vaccine. Journal of the American Medical Association, 324(13), 1296–1297.
Benckendorff, P., & Zehrer, A. (2013). A network analysis of tourism research. Annals of Tourism Research, 43, 121–149. https://doi.org/10.1016/j.annals.2013.04.005
Bhalla, N., Pan, Y., Yang, Z., & Payam, A. F. (2020). Opportunities and challenges for biosensors and nanoscale analytical tools for pandemics: COVID-19. ACS Nano, 14(7), 7783–7807. https://doi.org/10.1021/acsnano.0c04421
Bono, S. A., Villela, E. F. de M., Siau, C. S., Chen, W. S., Pengpid, S., Hasan, M. T., Sessou, P., Ditekemena, J. D., Amodan, B. O., Hosseinipour, M. C., Dolo, H., Fodjo, J. N. S., Low, W. Y., & Colebunders, R. (2021). Factors affecting COVID-19 vaccine acceptance: An international survey among low- and middle-income countries. Vaccines, 9(515), 1–19. https://doi.org/10.3390/vaccines9050515
Choudhary, O. P., Priyanka, & Singh, I. (2021). Vaccine certificate during domestic traveling: A potential initiative to prevent COVID-19 waves in India. Human Vaccines and Immunotherapeutics, 17(10), 3487–3488.
Cipto, B. (2022). Rivalitas AS vs China di era Biden. Yogyakarta: Pustaka Pelajar.
Daniels, J. P. (2021). Health experts slam Bolsonaro's vaccine comments. The Lancet, 397(10272), 361.
Donthu, N., Kumar, S., Mukherjee, D., Pandey, N., & Lim, W. M. (2021). How to conduct a bibliometric analysis: An overview and guidelines. Journal of Business Research, 133, 285–296. https://doi.org/10.1016/j.jbusres.2021.04.070
Dzulkhairi, M., Rani, M., Azmawati, N., Id, M., Maizuliana, H., & Id, S. (2022). Assessment of acceptability of the COVID-19 vaccine based on the health belief model among Malaysians-A qualitative approach. PLoS ONE, 17(6), 1–19.
Earnshaw, V. A., Eaton, L. A., Kalichman, S. C., Brousseau, N. M., Hill, E. C., & Fox, A. B. (2020). COVID-19 conspiracy beliefs, health behaviors, and policy support. Translational Behavioral Medicine, 10(4), 850–856.
Ellegaard, O., & Wallin, J. A. (2015). The bibliometric analysis of scholarly production: How great is the impact?. Scientometrics, 105, 1809-1831.
Fadli, A., Nugraha, A. W. W., Aliim, M. S., Taryana, A., Kurniawan, Y. I., & Purnomo, W. H. (2020). Simple correlation between weather and COVID-19 pandemic using data mining algorithm. IOP Conference Series: Materials Science and Engineering, 982, 1–10. https://doi.org/10.1088/1757-899X/982/1/012015
Ferranna, M., Cadarette, D., & Bloom, D. E. (2021). COVID-19 vaccine allocation: Modeling health outcomes and equity implications of alternative trategies. Engineering, 7(7), 924–935. https://doi.org/10.1016/j.eng.2021.03.014
Folayan, M. O., Brown, B., Haire, B., Ndembi, C. P. B., & Ndembi, N. (2021). Considerations for stakeholder engagement and COVID-19 related clinical trials’ conduct in sub-Saharan Africa. Developing World Bioethics, 21(1), 44–50.
Gao, Y., Wang, Y., Zhai, X., He, Y., Chen, R., Zhou, J., Li, M., & Wang, Q. (2017). Publication trends of research on diabetes mellitus and T cells (1997-2016): A 20-year bibliometric study. PLoS ONE, 12(9), 1–13.
Garrett, L. (2020). COVID-19: the medium is the message. The lancet, 395(10228), 942-943.
Gennaro, F. Di, Murri, R., Segala, F. V., Cerruti, L., Abdulle, A., Saracino, A., Bavaro, D. F., & Fantoni, M. (2021). Attitudes towards Anti-SARS-CoV2 vaccination among Healthcare Workers: Results from a national survey in Italy. Viruses, 13(371), 1–11. https://doi.org/10.3390/v13030371
Guidry, J. P. D., Perrin, P. B., Laestadius, L. I., Vraga, E. K., Miller, C. A., Fuemmeler, B. F., Burton, C. W., Ryan, M., & Carlyle, K. E. (2021). U.S. public support for COVID-19 vaccine donation to low- and middle-income countries during the COVID-19 pandemic. Vaccine, 39(17), 2452–2457.
Hamdan, N. E. A., Fahrni, M. L., & Lazzarino, A. I. (2022). COVID-19 Vaccination Prioritization Strategies in Malaysia: A Retrospective Analysis of Early Evidence. Vaccines, 11(1), 48.
Hamidah, I., Sriyono, S., & Hudha, M. N. (2020). A Bibliometric analysis of Covid-19 research using VOSviewer. Indonesian Journal of Science and Technology, 34-41.
Hashim, J. H., Adman, M. A., Hashim, Z., Radi, M. F. M., & Kwan, S. C. (2021). COVID-19 epidemic in Malaysia: Epidemic progression, challenges, and response. Frontiers in Public Health, 9, 1–19. https://doi.org/10.3389/fpubh.2021.560592
Husaeni, D. F. Al, & Nandiyanto, A. B. D. (2022). Bibliometric Using Vosviewer with Publish or Perish (using Google Scholar data): From Step-by-step Processing for Users to the Practical Examples in the Analysis of Digital Learning Articles in Pre and Post Covid-19 Pandemic. ASEAN Journal of Science and Engineering, 2(1), 19–46. https://doi.org/10.17509/ajse.v2i1.37368
Islam, M. S., Kamal, A.-H. M., Kabir, A., Southern, D. L., Khan, S. H., Hasan, S. M. M., Sarkar, T., Sharmin, S., Das, S., Roy, T., Harun, M. G. D., Chughtai, A. A., Homaira, N., & Seale, H. (2021). COVID-19 vaccine rumors and conspiracy theories: The need for cognitive inoculation against misinformation to improve vaccine adherence. PLos ONE, 16(5), 1–17. https://doi.org/10.1371/journal.pone.0251605
Jafar, A., Mapa, M. T., Sakke, N., Dollah, R., Joko, E. P., Atang, C., Ahmad, S. A., Hung, C. V., & Geogre, F. (2022). Vaccine hesitancy in East Malaysia (Sabah): A survey of the national COVID-19 immunisation programme. Geospatial Health, 17(s1), 75–84. https://doi.org/10.4081/gh.2022.1037
Javed, S., & Chattu, V. K. (2020). Strengthening the COVID-19 pandemic response, global leadership, and international cooperation through global health diplomacy. Health Promotion Perspectives, 10(4), 300–305. https://doi.org/10.34172/hpp.2020.48
Kamga, C., & Eickemeyer, P. (2021). Slowing the spread of COVID-19: Review of “Social distancing” interventions deployed by public transit in the United States and Canada. Transport Policy, 106, 25–36. https://doi.org/10.1016/j.tranpol.2021.03.014
King, E. J., & Dudina, V. I. (2021). COVID-19 in Russia: Should we expect a novel response to the novel coronavirus? Global Public Health, 16(8–9), 1237–1250.
Lee, S. T. (2023). Vaccine diplomacy: Nation branding and China’s COVID‑19 soft power play. Place Branding and Public Diplomacy, 19, 64–78.
Leung, X. Y., Sun, J., & Bai, B. (2017). Bibliometrics of social media research: A co-citation and co-word analysis. International Journal of Hospitality Management, 66, 35–45. https://doi.org/10.1016/j.ijhm.2017.06.012
Liang, D., Jong, M. De, Schraven, D., & Wang, L. (2022). Mapping key features and dimensions of the inclusive city: A systematic bibliometric analysis and literature study. International Journal of Sustainable Development and World Ecology, 29(1), 60–79. https://doi.org/10.1080/13504509.2021.1911873
Lockyer, B., Islam, S., Rahman, A., Dickerson, J., Pickett, K., Sheldon, T., Wright, J., Mceachan, R., & Sheard, L. (2021). Understanding COVID-19 misinformation and vaccine hesitancy in context: Findings from a qualitative study involving citizens in Bradford, UK. Health Expectations, 24, 1159–1168.
Loo, K. Y., & Letchumanan, V. (2021). COVID-19: Malaysia’s fight against this deadly virus. Progress in Microbes and Molecular Biology, 4(1), 1–11.
Makmun, A., & Hazhiyah, S. F. (2020). Tinjauan terkait pengembangan vaksin COVID-19. Molucca Medica, 13(2), 52–59. https://doi.org/10.30598/molmed.2020.v13.i2.52
Marzo, R. R., Ahmad, A., Abid, K., Khatiwada, A. P., Ahmed, A., Kyaw, T. M., Abidin, I. B. Z., Srithar, M., Sinnathamby, S., Sarvasundram, A. P., & Shrestha, S. (2022). Factors influencing the acceptability of COVID-19 vaccination: A cross-sectional study from Malaysia. Vacunas, 23(S1), S33–S40. https://doi.org/10.1016/j.vacun.2021.07.007
Mukhtar, H., Ahmad, H. F., Khan, M. Z., & Ullah, N. (2020). Analysis and evaluation of COVID-19 web applications for health professionals: Challenges and opportunities. Healthcare, 8(466), 1–26. https://doi.org/10.3390/healthcare8040466
Narasimha, P. T., Jena, P. R., & Majhi, R. (2021). Impact of COVID-19 on the Indian seaport transportation and maritime supply chain. Transport Policy, 110, 191–203.
Ndwandwe, D., & Wiysonge, C. S. (2021). COVID-19 vaccines. Current Opinion in Immunology, 71, 111–116. https://doi.org/10.1016/j.coi.2021.07.003
Puslitbang Bimas Agama dan Layanan Keagamaan, Badan Litbang dan Diklat, K. A. R. (2021). Respon dan kesiapan umat beragama atas rencana vaksinasi COVID-19. Jakarta: Puslitbang Bimas Agama dan Layanan Keagamaan, Badan Litbang dan Diklat Kementerian Agama Republik Indonesia.
Shaari, M. S., Masnan, F., Alias, N. S., & Rahim, R. T. A. (2021). How does covid-19 affect economy, business and society in Malaysia? AIP Conference Proceedings, 2339(1). https://doi.org/10.1063/5.0044603
Shah, S. H. H., Lei, S., Ali, M., Doronin, D., & Hussain, S. T. (2020). Prosumption: Bibliometric analysis using HistCite and VOSviewer. Kybernetes, 49(3), 1020–1045.
Shiferaw, Y. A. (2021). Regime shifts in the COVID-19 case fatality rate dynamics: A Markov-switching autoregressive model analysis. Chaos, Solitons and Fractals: X, 6. https://doi.org/10.1016/j.csfx.2021.100059
Singh, V. B. (2021). The human costs of COVID-19 policy failures in India. Nature Human Behaviour, 5(7), 810-811.
Sinuraya, R. K., Kusuma, A. S., Pardoel, Z. E., Postma, M. J., & Suwantika, A. A. (2022). Parents’ knowledge, attitude, and practice on childhood vaccination during the COVID-19 pandemic in Indonesia. Patient Preference and Adherence, 16, 105–112. https://doi.org/10.2147/PPA.S339876
Sohrabi, C., Alsafi, Z., O'neill, N., Khan, M., Kerwan, A., Al-Jabir, A., Losifidis, C., & Agha, R. (2020). World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International journal of surgery, 76, 71-76.
Star, T. (2021). Made-in-Malaysia COVID-19 vaccine expected to be ready in 2024. The Straits Times. https://www.straitstimes.com/asia/se-asia/made-in-malaysia-covid-19-vaccine-expected-to-be-ready-in-2024
Strangio, S. (2022). Indonesia launches first home-grown COVID-19 vaccine. The Diplomat. https://thediplomat.com/2022/10/indonesia-launches-first-home-grown-covid-19-vaccine/
Suah, J. L., Tok, P. S. K., Ong, S. M., Husin, M., Tng, B. H., Sivasampu, S., Thevananthan, T., Appannan, M. R., Zin, F. M., Zin, S. M., Yahaya, H., Rusli, N., Ujang, M. F., Ibrahim, H. M., Abdullah, N. H., & Peariasamy, K. M. (2021). Pick-ing Malaysia’s epidemic apart: Effectiveness of a diverse COVID-19 vaccine portfolio. Vaccines, 9(1381), 1–22. https://doi.org/10.3390/vaccines9121381
Tan, C., & Liew, C. Y. (2023). Health belief and behaviour: An analysis of the predictors for receiving COVID-19 vaccines in Malaysia. Public Administration and Policy, 26(1), 36–51. https://doi.org/10.1108/PAP-02-2022-0015
Tinungki, G. M., Robiyanto, R., & Hartono, P. G. (2022). The effect of COVID-19 pandemic on corporate dividend policy in Indonesia: The static and dynamic panel data approaches. Economies, 10(1), 11.
Wagner, A. L., Rajamoorthy, Y., & Taib, N. M. (2021). Impact of economic disruptions and disease experiences on COVID-19 vaccination uptake in Asia: A study in Malaysia. Narra J, 1(2), 1–8. https://doi.org/10.52225/narraj.v1i2.42
Wang, S., Su, F., Ye, L., & Jing, Y. (2022). Disinformation: A Bibliometric Review. International Journal of Environmental Research and Public Health, 19(24), 1–21. https://doi.org/10.3390/ijerph192416849
Widjaja, G., MS, M. Z., Hastuti, P., Nugraha, A. R., & Kusumawaty, I. (2021). Understanding COVID-19 vaccination program among Indonesian public: A challenge and hope for government. International Journal of Health Sciences, 5(3), 212–223.
Wong, L. P., Alias, H., Hashim, M. M. A. A. M., Lee, H. Y., AbuBakar, S., Chung, I., Hu, Z., & Lin, Y. (2022). Acceptability for COVID-19 vaccination: perspectives from Muslims. Human Vaccines & Immunotherapeutics, 18(5).
Yoda, T., & Katsuyama, H. (2021). Willingness to receive COVID-19 vaccination in Japan. Vaccines, 9(48), 1–8. https://doi.org/10.3390/vaccines9010048
Downloads
Published
How to Cite
Issue
Section
License
Please find rights and licences in Journal of Contemporary Governance and Public Policy. By submitting articles or article manuscripts, the author agrees to this policy. No special documents are required.
1. Licence
Use of articles will be governed by the Creative Commons Attribution-ShareAlike licence as currently displayed on the Creative Commons Attribution-ShareAlike 4.0 International Licence (CC BY-SA).
2. Author(s)' Warranties
The author warrants that the article is original, written by the stated author(s), has not been published before, contains no unlawful statements, does not infringe the rights of others, is subject to copyright that is vested exclusively in the author and free of any third-party rights, and that any necessary written permissions to quote from other sources have been obtained by the author(s).
3. User Rights
The spirit of Journal of Contemporary Governance and Public Policy is to disseminate articles published as freely as possible. Under the Creative Commons licence, Journal of Contemporary Governance and Public Policy permits users to copy, distribute, display, and perform the work. Users will also need to attribute authors and Journal of Contemporary Governance and Public Policy for distributing works in journal and other media of publication.
4. Rights of Authors
Authors retain all their rights to the published works, such as (but not limited to) the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. The right to use the substance of the article in future works, including lectures and books,
3. The right to reproduce the article for own purposes,
4. The right to enter into separate, additional contractual arrangements for the non-exclusive distribution of the article's published version (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal (Journal of Contemporary Governance and Public Policy).
5. Co-Authorship
If the article was jointly prepared by more than one author, any author submitting the manuscript warrants that he or she has been authorised by all co-authors to agree on this copyright and licence notice (agreement) on their behalf and agrees to inform his or her co-authors of the terms of this policy. Journal of Contemporary Governance and Public Policy will not be held liable for anything that may arise due to the author's internal dispute. Journal of Contemporary Governance and Public Policy will only communicate with the corresponding author.
6. Royalties
Being an open-access journal and disseminating articles for free under the Creative Commons licence term mentioned, the author(s) are aware that Journal of Contemporary Governance and Public Policy entitles the author(s) to no royalties or other fees.
7. Miscellaneous
Journal of Contemporary Governance and Public Policy will publish the article (or have it published) if the editorial process is successfully completed and the Journal or its sublicensee is obliged to proceed with its publication. The Journal also reserves the right to conform the article to its preferred style of punctuation, spelling, capitalisation, and usage.
